Fulgent Genetics Inc expected to post earnings of $5.86 a share - Earnings Preview

Fulgent Genetics

05/05/2021 01:49

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected to show
a rise in quarterly revenue when it reports results on May 6.
* The Temple City, California-based company is expected to
report   a 4,047.0% increase in revenue to $321.514 million from
$7.75 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
​* Refinitiv's mean analyst estimate for Fulgent Genetics Inc is
for earnings of $5.86 per share. For the same quarter last year,
the company reported a loss of 3 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Fulgent
Genetics Inc is $90.5​, about 18.1% above​ its last closing
price of $74.14. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  4.30        4.05       6.20      Beat    52.9
 Sep. 30 2020  0.55        0.55       2.08      Beat    277.3
 Jun. 30 2020  -0.01       -0.02      0.17      Beat    1,044.
                                                        4​
 Mar. 31 2020  0.02        0.02       -0.03     Missed  -242.9
 Dec.          ​           0.04       0.04      Met     1.3​
 31​ 2019​                                              
 Sep. 30 2019  0.03        0.03       0.14      Beat    344.4​
 Jun. 30 2019  0.00        0.00       0.06      Beat    4,100
 Mar. 31 2019  -0.01       -0.02      -0.06     Missed  -179.1
 This summary was machine generated May 5 at 00:49 GMT.  All
figures in US dollars unless otherwise stated